There were 178 press releases posted in the last 24 hours and 357,534 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image